![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 15, 2021 1:44:15 PM
ROBERT GIORDANO
Managing Director of Life Science
Bob’s career in the financial services industry spans 35 plus years, with a major concentration in investment banking, related advisory and consulting work on behalf of emerging life science companies. This includes drug development companies, medical device development companies, both diagnostic and therapeutic, medical informatics companies and health care companies. Bob holds a BA from St. John’s University, an LLB from St. John’s University Law School, and a FINRA Series 79 License.
VINCENT LABARBARA
Managing Director
Mr. LaBarbara has more than 30 years experience in management, acquisitions and financial investments. He presently serves as a Managing Director/Investment Banking at Network 1 Financial Securities, Inc.. Prior to his association with Network 1, Mr. LaBarbara acquired Skyebanc, Inc. a registered broker dealer with a specialty towards private equity, in May 2005 where he served as President and Chief Executive Officer. Prior to that, Mr. LaBarbara was a Partner and Managing Director of Commonwealth Associates from 1992 to 1998. His responsibilities included managing a very successful retail sales force. He was also a member of Commonwealth Associates’ Executive Committee, from which all corporate decision-making was finalized. In addition, he chaired the distribution of Commonwealth Associates’ public and private offerings for both retail and institutional sales. Mr. LaBarbara has served on the Board of Foxton’s North America, a subsidiary of Foxtons UK, the largest real estate broker in central London. He also sat on the Board of Berdy Medical Systems. He has also advised dozens of public and private companies in various capacities.
Over the last 25 years, Mr. LaBarbara has led or participated in the successful consummation of numerous public and private investments in excess of 300 million dollars for early stage and emerging-growth companies. He attended Kingsborough College and received degrees in accounting and finance. He also attended and completed advanced accounting courses from Pace University’s New York School of Finance.
Mr. LaBarbara holds Series 7, 63, 79 and 24 FINRA licenses.
Do not rely on my opinions when making investment decisions. They are only opinions and I am probably no smarter than you!
Recent XCRT News
- Form 1-U - Current Report Pursuant to Regulation A • Edgar (US Regulatory) • 05/10/2024 07:01:28 PM
- Form 1-U - Current Report Pursuant to Regulation A • Edgar (US Regulatory) • 05/06/2024 03:55:15 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM